Molecular Transport Medium Market Trends

  • Report ID: 4251
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT

Molecular Transport Medium Market - Growth Drivers and Challenges

Growth Drivers

  • Rise in the Number of Infectious Diseases Worldwide - According to WHO, the number of infectious and parasitic diseases touched 7.2 million in 2018 globally. Furthermore, in 2019, the number of cases of various infectious disease was estimated to rise globally such as, tuberculosis (8000), meningococcal disease (400), salmonella (55,000), and Lyme disease (35,000).Molecular transport medium is most suitable for the diagnosis of infectious diseases since it prevents the spreading of infection among the healthcare staff. MTM are known to preserve the sample to its initial state by keeping them close as mush as required. This process becomes helpful in preventing the spread of viruses in the environment for days and weeks. Hence, this factor is projected to hike the market growth over the forecast period.
  • Increasing Number of Diagnostic Tests - More than 3 billion Vitro diagnostic tests are conducted every year (both FDA-reviewed and lab-developed tests) across the globe.
  • Rise In Experiments in Laboratories and Research Institutes - According to the data by the World Bank, there were 1597 researchers involved in research and development activities per 1,000,000 people, as of 2018, up from 1412 per million in 2015.
  • Rising Awareness for the Health of Co-Workers in a Laboratory - Total fatal occupational injuries in healthcare practitioners and technical occupations decreased from 60 in 2016 to 51 in 2020, and healthcare support occupations raised from 30 in 2016 to 44 in 2020. Molecular transport medium is the best solution to prevent the spread of infection in co-workers and owing to this, healthcare providers highly prefer MTMs.
  • Growing Expenditure for R&D Activities – based on the data released by the World Bank, the health expenditure for research and development was stated to reach 2.63% up from 2.2% in 2028. Research and development of molecular transport medium is at its peak and growing health expenditure has been proved to be very beneficial for it.

Challenges

  • Unpredictable Nature of Seasonal Infections - There are multiple infectious diseases that spread in global population and their nature of spreading and affecting the can be quite unpredictable. This condition makes the molecular transport medium as ordinary as other mediums are. Hence, this factor can limit the market growth over the forecast period.
  • High Risk of False Results by Molecular Medium
  • Uncertain Occurrence of Infections Leading to the Adoption of a Conservative Approach

Base Year

2025

Forecast Year

2026-2035

CAGR

1.2%

Base Year Market Size (2025)

USD 1.04 billion

Forecast Year Market Size (2035)

USD 1.17 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of molecular transport medium is estimated at USD 1.05 billion.

The global molecular transport medium market size crossed USD 1.04 billion in 2025 and is likely to register a CAGR of over 1.2%, exceeding USD 1.17 billion revenue by 2035.

North America is anticipated to command a 36% share of the molecular transport medium market by 2035 owing to the wider availability of new diagnostic kits and OTC drugs.

Key players in the market include Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Medical Wire & Equipment Ltd, Titan Biotech Ltd., EKF Diagnostics Holdings plc, Trinity Biotech Plc., Puritan Medical Products Company LLC, Longhorn Vaccines and Diagnostics, LLC, Mylab Discovery Solutions Pvt. Ltd., 2B Scientific Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos